TISSUE AND ORGAN TRANSPLANTATION MARKET ANALYSIS

Tissue and Organ Transplantation Market, By Product Type (Tissue Products, Preservation Solution, Immunosuppressive Drugs), By Type of Transplant (Living Donor Transplant, Deceased Donor Transplant, Autograft Transplant, Xenograft Transplant , Allograft Transplant), By Application (Organ Transplantation, Tissue Transplantation) , By End User (Hospital, Transplant Centers, Tissue Banks, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In April 2024, United Therapeutics Corporation, a public benefit corporation, announced the successful transplantation of the world's first UThymoKidney into a living person
In February 2022, Amnio Technology, a tissue grafting company, introduced two new products under the PalinGen membrane line: the PalinGen Dual-Layer Membrane and the Dual Layer PalinGen X-Membrane. These allografts, similar to the entire PalinGen membrane family, are minimally manipulated, and are intended for homologous use, and does not contain chorion.
In February 2022, Orthofix Medical , global spine and orthopedics company launched Opus BA, a synthetic bioactive bone graft solution that is designed for cervical and lumbar spine fusion procedures. Opus BA is utilized to fill bone voids or gaps within the skeletal system.